AI Article Synopsis
- A 38-year-old male with a history of mild COVID-19 experienced a worsening occipital headache while hospitalized for alcoholic hepatitis.
- Medical evaluations revealed a small, right-sided subarachnoid hemorrhage with no signs of coagulopathy or aneurysm.
- This case highlights the need to thoroughly investigate headaches in COVID-19 patients, even if the infection seems mild, as they may indicate potential intracranial bleeding.
Article Abstract
Both subarachnoid hemorrhage and intraparenchymal hemorrhage have been reported in patients with coronavirus disease 2019 (COVID-19) infection. We report a 38-year-old male patient who was initially admitted for alcoholic hepatitis and had a mild COVID-19 infection that was confirmed 10 days prior to presentation. During his hospitalization, he reported worsening of his occipital headache that started when he tested positive for COVID-19. Neurological examination was intact and no history of trauma, hypertension, illicit drug use, or family history of brain aneurysm was reported. Investigating his worsening headache revealed a tiny, right-sided, posterior subarachnoid hemorrhage. No coagulopathy was evident. No aneurysm was seen on the cerebral angiogram. The patient was managed conservatively. This case raises the point of the importance of investigating headaches even in mild COVID-19 infection, as it may herald intracranial bleeding.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946690 | PMC |
| http://dx.doi.org/10.7759/cureus.34103 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
ObjectivePatients who do not wait (DNW) to be seen are a problem for emergency department (ED) care. The aim of this study was to identify the rate and reasons of DNW patients during 1month of the COVID-19 pandemic.MethodsAn observational cohort study of DNW patients presenting to Austin Hospital ED was carried out in August 2021.
View Article and Find Full Text PDFComparisons of echocardiographic findings of COVID-19 patients in intensive care units before and after the omicron variant propagation.
J Echocardiogr
December 2024
Division of Cardiology, Department of Internal Medicine, Tokai University School of Medicine, Shimokasuya 143, Isehara-shi, Kanagawa, 259-1193, Japan.
Purpose: Few investigational reports have evaluated the status of cardiovascular manifestations of coronavirus disease 2019 (COVID-19) during the Omicron dominance period. In this study, we aimed to investigate the cardiac function parameters and clinical outcomes of patients with COVID-19 before and after the Omicron variant (OV) propagation.
Methods: We retrospectively analyzed the data of 88 adult patients with COVID-19 who underwent clinically indicated standard transthoracic echocardiography (TTE) in intensive care wards.
[Epicutaneous tests with dental materials before and during COVID-19 pandemic in the Central Hungary region].
Orv Hetil
December 2024
1 Észak-pesti Centrumkórház-Honvédkórház, Dermatoallergológiai Szakambulancia Budapest, Németvölgyi út 21., 1126 Magyarország.
[Prevention of Streptococcus pneumoniae infections in adults].
Orv Hetil
December 2024
3 Semmelweis Egyetem, Általános Orvostudományi Kar, Belgyógyászati és Hematológiai Klinika, Infektológiai Tanszéki Csoport Budapest Magyarország.
[Molecular Ion Channel Blockers of Influenza A and SARS-CoV-2 Viruses].
Mol Biol (Mosk)
December 2024
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk, 630090 Russia.
Molecules were proposed to block the functional cycles of the influenza virus A and SARS-CoV- 2. The blocker molecules efficiently bind inside the M2 and E channels of influenza A and SARS-CoV-2 viruses and block diffusion of H^(+)/K^(+) ions, thus distorting the virus functional cycle. A family of positively charged (+2 e.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!